Agf Investments Inc. Amarin Corp Plcuk Transaction History

Agf Investments Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$4.26 - $6.5 $5.54 Million - $8.46 Million	-1,301,492 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$4.04 - $5.31 $2,149 - $2,824	-532 Reduced 0.04%	1,301,492 $6.36 Million
Q3 2020 Nov 12, 2020	BUY	$3.64 - $7.76 $1.46 Million - $3.11 Million	400,441 Added 44.42%	1,302,024 $5.48 Million
Q1 2020 May 08, 2020	BUY	$4.0 - $21.53 $1.5 Million - $8.07 Million	375,000 Added 71.21%	901,583 $3.61 Million
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $763,950 - $1.27 Million	55,000 Added 11.66%	526,583 $7.98 Million
Q2 2019 Jul 30, 2019	BUY	$16.27 - $20.51 $1.64 Million - $2.06 Million	100,650 Added 27.13%	471,583 $9.14 Million
Q1 2019 May 10, 2019	BUY	$12.61 - $22.33 $2.14 Million - $3.8 Million	170,000 Added 84.61%	370,933 $7.7 Million
Q4 2018 Feb 08, 2019	BUY	$12.41 - $22.98 $2.49 Million - $4.62 Million	200,933 New	200,933 $2.74 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.